ABSTRACT The somatostatin analog D-Phe-Cys-Phe-D-TrpLys-Thr-Cys-NH-CH(CH2OH)CHOHCH3 
The tetradecapeptide somatostatin has been reported to interact weakly with opiate receptors. In crude rat brain homogenates, only high concentrations of somatostatin displace [3H]-naloxone or [3H]dihydromorphine from their binding sites (1, 2) . Its analgesic properties are apparent from results obtained in the tail flick test in mice in which, after intracerebroventricular (i.c.v.) administration, somatostatin produces a naloxonereversible prolongation of the response latency (2) . Furthermore, in the rat, somatostatin (i. c. v. administration) antagonizes the behavioral effects of previously administered ,B-endorphin (3) .
On the basis of these results, it was decided to investigate the possible interactions of the stable and potent somatostatin analog D-Phe-Cys-Phe-D-Trp-Lys-Thr-Cys-NH-CH(CH2OH)-CHOHCH3, code named SMS 201-995 (4), with opiate receptors.
MATERIALS AND METHODS Binding Studies. The brains (minus cerebellum) of male Sprague-Dawley rats and albino guinea pigs were used for binding studies. Preparation of the homogenate and incubation conditions were essentially as described (5 
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The publication costs ofthis article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. §1734 solely to indicate this fact. 49 days. The excitability of the cell was monitored by injection of a depolarizing current pulse through the recording electrode (0.33 Hz, 120 msec, 0.3 nA; indicated in F by star). Immediately after the intracellular pulse, field stimulation (0.1 msec, 4 pA; indicated in F by arrow) elicited in the pyramidal cell a short latency excitatory postsynaptic potential followed by a long-lasting inhibition (A). During application of 1 PM FK 33-824 (B), the synaptic responses were transformed into bursting discharges whereby the inhibitory responses were abolished. Bath application of 10 HM somatostatin (C) and 10 ,uM SMS 201-995 (D) had, 5 min after onset of the drug perfusion, no effect on either the excitability of the cell or the synaptic responses. In the presence of 10 PM somatostatin, 1 (17, 18) or an inhibitory action (19) of somatostatin. In accordance with the present results, desensitization usually developed rapidly, so that consecutive applications of the peptide resulted in decreased response. It is to be noted that SMS 201-995 persisted in blocking the opiate effects even after the intrinsic effects of the peptide had subsided.
It was not possible to establish the relative affinities of SMS 201-995 for different types of opiate receptors by using the mouse vas deferens preparation (20) because the compound has an intrinsic inhibiting effect in this tissue that may be related to an action at the somatostatin receptor (21) .
A structural relationship between SMS 201-995 and any of the known opioids is not apparent. Although two conformationally constrained enkephalins containing cysteine2 and cysteine5 interact with the opiate receptor (22) , a molecular interrelationship awaits further clarification.
